Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Search by expertise, name or affiliation
Pharmacotherapy for major depression in children and adolescents
Karen Dineen Wagner
Psychiatry and Behavioral Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
43
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacotherapy for major depression in children and adolescents'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacotherapy
100%
Major Depressive Disorder
100%
Depression in Adolescents
100%
Antidepressants
100%
Depression in children
100%
Placebo
50%
Selective Serotonin Reuptake Inhibitors
50%
Efficacy Study
50%
Fluoxetine
50%
Suicidality
50%
Treatment Trials
50%
Citalopram
50%
Primary Outcome Measure
50%
Childhood Depression
50%
Treatment Recommendations
50%
Sertraline
50%
Social-emotional
50%
Social Development
50%
Academic Development
50%
Serious Illness
50%
Acute Efficacy
50%
Emotional Development
50%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Pharmacotherapy
100%
Major Depression
100%
Antidepressant
100%
Placebo
50%
Selective Serotonin Reuptake Inhibitor
50%
Efficacy Study
50%
Fluoxetine
50%
Citalopram
50%
Sertraline
50%
Neuroscience
Major Depressive Disorder
100%
Antidepressant
100%
Selective Serotonin Reuptake Inhibitor
50%
Fluoxetine
50%
Placebo
50%
Citalopram
50%
Childhood Depression
50%
Sertraline
50%